Aravax is a clinical stage biotechnology company developing a novel peptide-based immunotherapy, PVX108, for the treatment of peanut allergy. Aravax is striving to improve the lives of patients living with peanut allergies by developing a therapy that precisely targets the underlying cause of disease, bringing benefits in safety and convenience.
Company Details
- Employees
- 13
- Address
- Level 9, 31 Queens Street, Melbourne,victoria 3000,australia
- Phone
- 610396570700
- in****@****.com.au
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aravax.com.au
- Keywords
- Certa Therapeutics.
- HQ
- Melbourne, Victoria
Aravax Questions
Aravax's helpline number is 610396570700
Aravax's website is aravax.com.au
Aravax's LinkedIn profile is https://au.linkedin.com/company/aravax
Aravax has
13 employees.
View email and phone details for 13
employees at Aravax.
Aravax's industry is
Biotechnology Research
Aravax's top competitors are
Tenmile,
Telix Pharmaceuticals Limited,
Nutromics,
Atmo Biosciences,
Currus Biologics Pty Ltd,
Denteric Pty Ltd,
Ena Respiratory,
Certa Therapeutics,
Brandon Capital,
Prota Therapeutics Pty Ltd.
Aravax's support email address is info@aravax.com.au
Aravax's categories are Biotechnology Research
